$FLNA

$0.61 -$0.02 (3.73%) Close

$FLNA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$FLNA Management Team

Dr. Claude Nicaise

Independent Chairman of the Board

Age 73

Compensation $212.9K USD

Sex Male

Mr. Richard Barry

President

Chief Executive Officer

Director

Age 66

Compensation $16.73M USD

Sex Male

Mr. Eric Schoen

Chief Financial Officer

Age 56

Compensation $3.851M USD

Sex Male

Dr. Angelique Bordey

Senior Vice President - Neuroscience

Age -

Compensation -

Sex Female

Dr. Jack Moore

Senior Vice President - Clinical Development

Age -

Compensation -

Sex Male

Mr. R. Christopher Cook

Chief Operating and Legal Officer

Age 61

Compensation $1.269M USD

Sex Male

Ms. Freda Nassif

Chief Business Officer

Age 49

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Dr. Claude Nicaise Independent Chairman of the Board	73	$212.9K USD	Male
Mr. Richard Barry President Chief Executive Officer Director	66	$16.73M USD	Male
Mr. Eric Schoen Chief Financial Officer	56	$3.851M USD	Male
Dr. Angelique Bordey Senior Vice President - Neuroscience	-	-	Female
Dr. Jack Moore Senior Vice President - Clinical Development	-	-	Male
Mr. R. Christopher Cook Chief Operating and Legal Officer	61	$1.269M USD	Male
Ms. Freda Nassif Chief Business Officer	49	-	Female

Board of Directors

From the proxy statement filed Apr 28, 2026

Directors

serving now

Independent

0 of 1

stated in the proxy; 6 not stated

Average tenure

8.1 years

from year joined

CEO also chairs the board

Claude Nicaise, M.D.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Richard J. Barry CEO	67	2021 5 years	Not independent	None stated	Sarepta Therapeutics, Inc.	Paid as CEO
Robert Anderson, Jr.	60	2023 3 years	Not stated	None stated	None stated	$98,492
Dawn C. Bir	55	2025 1 year	Not stated	None stated	Geron Corporation, Soleno Therapeutics	$213,111
Pierre Gravier	41	2023 3 years	Not stated	None stated	None stated	$98,117
Robert Z. Gussin, Ph.D. Leaving at the meeting	88	2003 23 years	Not stated	None stated	None stated	$96,242
Claude Nicaise, M.D. Board chair	74	2023 3 years	Not stated	None stated	Sarepta Therapeutics, Inc.	$119,867
Patrick J. Scannon, M.D., Ph.D.	78	2007 19 years	Not stated	None stated	None stated	$86,867

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$FLNA Management Team

Dr. Claude Nicaise

Mr. Richard Barry

Mr. Eric Schoen

Dr. Angelique Bordey

Dr. Jack Moore

Mr. R. Christopher Cook

Ms. Freda Nassif

Board of Directors

Related-party transactions

No related-party transactions disclosed